The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.
Article obtained from BioPhotonics RSS Feed.
PerkinElmer announced it will acquire Horizon Discovery, a Cambridge, England-based cell engineering company. The acquisition will expand PerkinElmer’s life sciences discovery and applied genomics solutions offerings, and bring together the companies’ genotypic and phenotypic approaches for drug discovery and development. The transaction carries a total enterprise value of approximately $368 million. The deal is worth $383 million, PerkinElmer announced.
“One of the key fundamentals for molecular research and drug discovery is being able to knock down a gene or function and explore the results to discover actionable insights and new clinical trial candidates faster,” said Prahlad Singh, president and CEO of…READ MORE